Skip to content

Dietary Nucleotides and Ribose on Muscle Fuel Utilisation

The Effect of Dietary Nucleotides and Ribose on Muscle Fuel Utilisation and Exercise Performance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03659890
Acronym
FUN
Enrollment
13
Registered
2018-09-06
Start date
2018-06-28
Completion date
2020-02-02
Last updated
2020-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Nucleotides are the building blocks for a variety of molecules, including ATP, which is broken down in the skeletal muscle cells to provide fuel for exercise. Nucleotides can be obtained from the diet, and produced or salvaged by the body. Though nucleotides provide the building blocks for ATP, the sugar ribose has been suggested to be rate limiting for synthesising ATP. Previous studies have shown a decrease in ATP levels in the muscle after intense exercise, and this is linked to fatigue. Other studies have also reported benefits of nucleotide and/or ribose supplementation on exercise performance. However, any potential link between ATP metabolism and exercise performance has not been explored. This study will look at the effects of nucleotide and nucleotide-ribose supplementation in fuel utilisation and performance in skeletal muscle during endurance exercise.

Interventions

DIETARY_SUPPLEMENTLow nucleotide

2 week, twice daily, supplementation with a nucleotide-depleted mycoprotein drink, with added dextrose

DIETARY_SUPPLEMENTHigh nucleotide

2 week, twice daily, supplementation with a nucleotide-rich mycoprotein drink, with added dextrose

DIETARY_SUPPLEMENTHigh nucletide + Ribose

2 week, twice daily, supplementation with a nucleotide-rich mycoprotein drink, with added ribose

Sponsors

University of Exeter
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI between 18 and 30

Exclusion criteria

* On medication (except contraception) * Smokers * Diagnosed with any metabolic or cardiovascular conditions * Muscle or bone injuries * BMI \< 18 or \> 30

Design outcomes

Primary

MeasureTime frame
Changes in muscle ATP concentrationsAfter each supplementation cycle (day 15 of each cycle): baseline (fasted and before exercise), immediately after glycogen depleting exercise (after exercising for 1:30 - 2 hours), immediately after 15 minute time trial and after 3-hour recovery

Secondary

MeasureTime frame
Changes in muscle glycogen concentrationsAfter each supplementation cycle (day 15 of each cycle): baseline (fasted and before exercise), immediately after glycogen depleting exercise (after exercising for 1:30 - 2 hours), immediately after 15 minute time trial and after 3-hour recovery
Blood lactate concentrationsAfter supplementation cycle (day 15): baseline and at 15 minute intervals up 1 hour during glycogen depleting exercise
Blood glucose concentrationsAfter supplementation cycle (day 15): baseline and at 15 minute intervals up 1 hour during glycogen depleting exercise
Serum uric acid concentrationsMeasured at baseline and of days 6, 8 and 15 of each supplementation cycle

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026